Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Meta Platforms (Facebook)
META
$1.4T
| $794M | 0.39% |
2,767,363
-107,293
| -4% | -$26.5M |
|
27
PUT
Advanced Micro Devices
AMD
$773B
| $778M | 0.38% |
6,832,900
+2,491,400
| +57% | +$259M |
|
28
PUT
ExxonMobil
XOM
$679B
| $718M | 0.35% |
6,698,000
+2,698,700
| +67% | +$294M |
|
29
PUT
Palo Alto Networks
PANW
$292B
| $673M | 0.33% |
5,264,000
+1,760,800
| +50% | +$183M |
|
|
30
Home Depot
HD
$335B
| $561M | 0.28% |
1,806,896
+1,732,872
| +2,341% | +$512M |
|
31
Alphabet (Google) Class C
GOOG
$4.18T
| $552M | 0.27% |
4,564,501
+2,939,662
| +181% | +$340M |
|
32
Boston Scientific
BSX
$73B
| $526M | 0.26% |
10,220,076
+135,093
| +1% | +$7.06M |
|
|
33
PUT
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $503M | 0.25% |
12,404,800
+4,327,200
| +54% | +$176M |
|
|
34
CALL
Alphabet (Google) Class A
GOOGL
$4.22T
| $495M | 0.24% |
4,137,100
+1,924,300
| +87% | +$221M |
|
35
CALL
NVIDIA
NVDA
$5.2T
| $486M | 0.24% |
11,490,000
+3,598,000
| +46% | +$119M |
|
36
PUT
Goldman Sachs
GS
$303B
| $469M | 0.23% |
1,455,600
+526,100
| +57% | +$173M |
|
|
37
PUT
Alphabet (Google) Class C
GOOG
$4.18T
| $469M | 0.23% |
3,873,800
+2,621,000
| +209% | +$303M |
|
38
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $463M | 0.23% |
11,332,100
+641,700
| +6% | +$26.3M |
|
39
PUT
Chevron
CVX
$403B
| $458M | 0.23% |
2,912,800
+586,400
| +25% | +$94M |
|
|
ATVI
40
DELISTED
Activision Blizzard
ATVI
| $457M | 0.23% |
5,425,921
+795,913
| +17% | +$64.4M |
|
|
41
PUT
Salesforce
CRM
$171B
| $445M | 0.22% |
2,104,600
+964,800
| +85% | +$197M |
|
42
Adobe
ADBE
$109B
| $426M | 0.21% |
871,811
+421,500
| +94% | +$170M |
|
|
43
Chevron
CVX
$403B
| $422M | 0.21% |
2,684,414
+1,822,413
| +211% | +$292M |
|
|
HZNP
44
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $417M | 0.21% |
4,058,491
-249,263
| -6% | -$26.3M |
|
45
Walmart Inc
WMT
$825B
| $405M | 0.2% |
7,729,401
+1,560,756
| +25% | +$78.7M |
|
46
CALL
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $405M | 0.2% |
12,012,100
+1,170,800
| +11% | +$38.2M |
|
|
47
Alphabet (Google) Class A
GOOGL
$4.22T
| $397M | 0.2% |
3,313,101
+970,055
| +41% | +$112M |
|
48
PUT
Netflix
NFLX
$331B
| $389M | 0.19% |
8,821,000
+6,189,000
| +235% | +$228M |
|
49
Eli Lilly
LLY
$1.12T
| $384M | 0.19% |
818,688
+815,226
| +23,548% | +$342M |
|
|
50
Vertex Pharmaceuticals
VRTX
$139B
| $375M | 0.19% |
1,066,718
+1,059,682
| +15,061% | +$357M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.